Bruker Corp (BRKR)
81.39
+0.80
(+0.99%)
USD |
NASDAQ |
Apr 26, 14:49
Bruker Accounts Payable (Quarterly): 202.70M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 202.70M |
September 30, 2023 | 181.50M |
June 30, 2023 | 188.80M |
March 31, 2023 | 196.20M |
December 31, 2022 | 178.40M |
September 30, 2022 | 157.70M |
June 30, 2022 | 154.90M |
March 31, 2022 | 161.20M |
December 31, 2021 | 147.40M |
September 30, 2021 | 141.10M |
June 30, 2021 | 142.60M |
March 31, 2021 | 152.30M |
December 31, 2020 | 134.60M |
September 30, 2020 | 113.90M |
June 30, 2020 | 119.20M |
March 31, 2020 | 127.00M |
December 31, 2019 | 118.40M |
September 30, 2019 | 116.60M |
June 30, 2019 | 123.70M |
March 31, 2019 | 126.50M |
December 31, 2018 | 104.50M |
September 30, 2018 | 100.00M |
June 30, 2018 | 104.60M |
March 31, 2018 | 104.70M |
December 31, 2017 | 90.80M |
Date | Value |
---|---|
September 30, 2017 | 94.80M |
June 30, 2017 | 91.70M |
March 31, 2017 | 94.70M |
December 31, 2016 | 86.10M |
September 30, 2016 | 93.30M |
June 30, 2016 | 88.00M |
March 31, 2016 | 95.10M |
December 31, 2015 | 72.10M |
September 30, 2015 | 87.40M |
June 30, 2015 | 84.40M |
March 31, 2015 | 87.10M |
December 31, 2014 | 76.00M |
September 30, 2014 | 98.50M |
June 30, 2014 | 102.20M |
March 31, 2014 | 116.40M |
December 31, 2013 | 74.80M |
September 30, 2013 | 82.90M |
June 30, 2013 | 69.50M |
March 31, 2013 | 75.80M |
December 31, 2012 | 69.60M |
September 30, 2012 | 78.00M |
June 30, 2012 | 364.70M |
March 31, 2012 | 387.20M |
December 31, 2011 | 72.30M |
September 30, 2011 | 327.10M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
113.90M
Minimum
Sep 2020
202.70M
Maximum
Dec 2023
150.43M
Average
147.40M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Azenta Inc | 40.24M |
Harvard Bioscience Inc | 5.554M |
Bionano Genomics Inc | 10.38M |
Akoya Biosciences Inc | 11.78M |
Singular Genomics Systems Inc | 2.587M |